+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 40 Pages
  • September 2020
  • GlobalData
  • ID: 4125956
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TSO3 Inc (TSO3) design, develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.

TSO3 Inc Key Recent Developments

Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12, 2019: TSO3 reports second quarter 2019 results
May 06, 2019: TSO3 reports first quarter 2019 results
Apr 02, 2019: TSO3 announces changes to the Board of Directors
Mar 27, 2019: TSO3 reports fourth quarter and full year 2018 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • TSO3 Inc - Key Facts
  • TSO3 Inc - Key Employees
  • TSO3 Inc - Key Employee Biographies
  • TSO3 Inc - Major Products and Services
  • TSO3 Inc - History
  • TSO3 Inc - Company Statement
  • TSO3 Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 – Company Analysis
  • Company Overview
  • TSO3 Inc - Business Description
  • TSO3 Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • TSO3 Inc - Strengths
  • TSO3 Inc - Weaknesses
  • TSO3 Inc - Opportunities
  • TSO3 Inc - Threats
  • TSO3 Inc - Key Competitors

Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
  • TSO3 Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments
  • Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
  • Aug 12, 2019: TSO3 reports second quarter 2019 results
  • May 06, 2019: TSO3 reports first quarter 2019 results
  • Apr 02, 2019: TSO3 announces changes to the Board of Directors
  • Mar 27, 2019: TSO3 reports fourth quarter and full year 2018 results

Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • TSO3 Inc, Key Facts
  • TSO3 Inc, Key Employees
  • TSO3 Inc, Key Employee Biographies
  • TSO3 Inc, Major Products and Services
  • TSO3 Inc, History
  • TSO3 Inc, Subsidiaries
  • TSO3 Inc, Key Competitors
  • TSO3 Inc, Ratios based on current share price
  • TSO3 Inc, Annual Ratios
  • TSO3 Inc, Annual Ratios (Cont...1)
  • TSO3 Inc, Interim Ratios
  • TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
  • TSO3 Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • TSO3 Inc, Performance Chart (2014 - 2018)
  • TSO3 Inc, Ratio Charts
  • TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • TSO3 Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Steris Corp
  • Olympus Corporation of the Americas
  • Johnson & Johnson
  • Getinge AB
  • Custom Ultrasonics Inc
  • Cantel Medical Corp